SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

The NRC is back to five commissioners

January 5, 2026, 10:46AMNuclear News

Douglas Weaver, nominated to the Nuclear Regulatory Commission by President Trump and confirmed by the U.S. Senate, was sworn in on December 22 as a commissioner for a term ending June 30,...